Key result
GeminiOne TEER achieves ~90% 1-year clinical success in high-risk severe degenerative mitral regurgitation.
Answers are grounded in this paper and cite their sources.
Demonstrates 89.84% one-year clinical success with GeminiOne transcatheter repair in degenerative mitral regurgitation, highlighting viable domestic device innovation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yunpeng Zhu (2026) conducted an editorial in Symptomatic moderate-to-severe or severe degenerative mitral regurgitation (DMR) (n=120). GeminiOne transcatheter edge-to-edge repair (TEER) system vs. Prespecified performance goal (single-arm study) was evaluated on Clinical success at 1 year (freedom from all-cause death, mitral reintervention, and residual mitral regurgitation >2+) (95% CI 84.56%-95.46%). The GeminiOne TEER system achieved 1-year clinical success in 89.84% of high-risk patients with severe degenerative mitral regurgitation.
Synapse has enriched 10 related papers. Consider them for comparative context: